Special collections

830 Targeting cellular senescence to increase CAR-T cell fitness
Rashmi Bankoti, Hazal Pektas Akbal, Maddalena Adorno, Benedetta Di Robilant

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A497; DOI: 10.1136/jitc-2020-SITC2020.0830
832 Unravelling human melanoma heterogeneity by 6-color multiplex immunofluorescence to overcome recurrence and resistance to therapy
Marcella Willemsen, Jenny Bulgarelli, Sudhir Kumar, Massimo Guidoboni, John Kyte, Irwin Davidson, Rosalie Luiten

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A498; DOI: 10.1136/jitc-2020-SITC2020.0832
833 The epigenomic landscape of human glioma-associated myeloid cells
Pravesh Gupta, Dapeng Hao, Krishna Bojja Bojja, Tuan Tran, Minghao Dang, Jianzhuo Li, Atul Maheshwari, Nicholas Navin, Linghua Wang, Krishna Bhat

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A498-A499; DOI: 10.1136/jitc-2020-SITC2020.0833
835 Structural difference caused by mutated residues is correlated with immunogenicity of neoantigens and specificity of reactive T cells
Tomoyo Shinkawa, Serina Tokita, Takayuki Kanaseki, Toshihiko Torigoe

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A499-A500; DOI: 10.1136/jitc-2020-SITC2020.0835
834 CRISPR-mediated in situ editing of liver resident macrophages for treating liver cancers
Zhutian Zeng, Wei Liu

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A499; DOI: 10.1136/jitc-2020-SITC2020.0834
838 Phenotypic and functional signatures of peripheral and tumor-resident γδ T cells are informative for outcome of checkpoint blockade in melanoma
Graham Pawelec, Kilian Wistuba-Hamprecht, Kilian Wistuba-Hamprecht

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A500-A501; DOI: 10.1136/jitc-2020-SITC2020.0838
836 Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy
Laura Ridgley, Angus Dalgleish, Mark Bodman-Smith

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A500; DOI: 10.1136/jitc-2020-SITC2020.0836
837 Interleukin-10 drives the development of T regulatory type 1 (Tr1) cells and is a target for immunotherapy
Yanchun Ma, Vera Bauer, Tanja Riedel, Thomas Hofer, Martin Roecken, Ralph Mocikat

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A500; DOI: 10.1136/jitc-2020-SITC2020.0837
839 Transcriptomic profiling of T-cell populations in non-muscle invasive and muscle invasive bladder cancer
Viktor Sincic, Milad Abolhalaj, Henrik Lilljebjörn, Alar Aab, Karin Hagerbrand, Peter Ellmark, Thoas Fioretos, Carl Borrebaeck, Fredrik Liedberg, Kristina Lundberg

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A501; DOI: 10.1136/jitc-2020-SITC2020.0839
841 CRISPR Cas9 library screen in primary T cells and diffuse large B cell lymphoma cells to identify modulators in tumor-immune interaction
Qian Li, Zhengang Peng

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A502; DOI: 10.1136/jitc-2020-SITC2020.0841

Main menu

Special collections

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Special collections

Pages